Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The candidate tumour suppressor gene
MMAC1
/PTEN located at chromosome 10q23.3 has been reported to be frequently mutated in a number of solid tumours. Less is known about its status in leukaemia. In the present study we first analysed 13 leukaemia cell lines for mutations and homozygous deletions in
MMAC1
/PTEN using PCR and denaturing gradient gel electrophoresis (DGGE). We identified an intragenic deletion including
MMAC1
/PTEN exons 2-5 in an acute myelocytic leukaemia cell line, HL-60 blast, and an insertion of four nucleotides in exon 5 in an acute monocytic leukaemia cell line, U937. Analysis of 59 patients with acute myeloid leukaemia (AML), 26 patients with myelodysplastic syndromes (MDS) and 10 patients with
chronic myeloid leukaemia
(
CML
) only revealed a polymorphic base substitution in codon 44 in one AML patient, suggesting that mutations in the
MMAC1
/PTEN gene are infrequent genetic aberrations in myeloid leukaemia.
...
PMID:Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders. 1096 70